SITC 2021 Booth #413
November 10-14, 2021
Advancing cancer and immunotherapy research with immunosequencing
The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting (SITC 2021) provides a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer.
Adaptive is excited to be hosting a special symposium during the event, where we will be highlighting exciting research taking place across the cancer research landscape and how immune repertoire profiling with the immunoSEQ Technology is uniquely suited to answer questions related to immuno-oncology. If you are attending SITC in-person, we hope you’ll stop by booth #413 and connect.
Utilizing immunosequencing in cancer research and immunotherapy
Independence Ballroom at the Marriott Marquis Washington DC
Friday, November 12 | 1:30-2:30pm
Learn about immunoSEQ® and how our science plays a role in the solid tumor setting as well as transgenic T-cell receptor adoptive cell therapies.
Katie Boland, DVM, Ph.D.
Kellie N. Smith, Ph.D.
Johns Hopkins University School of Medicine
Using immunoSEQ® in the solid tumor setting
Theodore Scott Nowicki, MD, Ph.D.
University of California Los Angeles
Transgenic T-cell receptor adoptive cell therapies: addressing epigenetic suppression & optimizing therapies with immunosequencing
immunoSEQ Product Resources
Learn more about immunoSEQ Assay by downloading these helpful resources:
Have Questions? Need to speak with someone?
Learn how immunoSEQ® T-MAP™ COVID can help uncover the T-cell immune response in COVID-19.Learn More
Looking for more information? Help with experimental design or technical support? Interested in speaking to someone?Contact Us
Access technical documents for getting started with the immunoSEQ® Service product, grant writing support, and FAQs.Learn More